Health in Tunisia 1,260 indicators covering health for Tunisia. IndicatorLatest Year10-yr change Rank Height-for-age <-2 SD (Stunting) Modeled Estimates, Numbers Affected 76.89 2024 down 16.0% 11th Weight-for-height >+2 SD (overweight), Modeled Estimates 17.48 2024 up 17.4% 1st Weight-for-height >+2 SD (Overweight) Modeled Estimates, Numbers 151.48 2024 down 3.1% 9th Percentage of surviving infants who received the third dose of 97 2025 down 1.0% 8th Tuberculosis prevalence rate 38 per 1000,000 population, WHO 2011 up 22.6% 51st Refugees under 18 years old, by country of origin 800 2025 up 23.1% 14th Compliance with international health regulations 55 2016 down 12.7% 116th Number of disruptions to health services attributed to disasters 2 2013 down 33.3% 25th Prevalence of undernourishment 0 population 2011 — 40th Deaths and disappearances during migration 635 2024 up 15,775.0% 4th Incidence of tuberculosis, high uncertainty bound 34 per 100,000 people 2011 up 25.9% 51st Incidence of tuberculosis, low uncertainty bound 26 per 100,000 people 2011 up 23.8% 50th Tuberculosis prevalence rate, high uncertainty bound 71 per 1000,000 population, WHO 2011 up 24.6% 51st Tuberculosis prevalence rate, low uncertainty bound 15 per 1000,000 population, WHO 2011 up 25.0% 52nd Stillbirth rate 9.19 2023 down 19.5% 8th Universal health coverage index for reproductive, maternal, newborn 81 2023 up 14.1% 1st Coverage of essential health services 76 2023 up 8.6% 7th Stillbirths 1,555 2023 down 38.8% 11th Maternal mortality ratio 35.71 2023 down 16.5% 8th Maternal deaths 59.9 2023 down 36.4% 11th Number of imported cases of cutaneous leishmaniasis reported 0 2020 — 34th Number of imported cases of visceral leishmaniasis reported 0 2020 — 22nd Exclusive breastfeeding under six months 17.8 2023 up 109.4% 63rd Exclusive breastfeeding under six months 14.95 2023 up 68.5% 61st Exclusive breastfeeding 17.82 2023 up 109.8% 63rd Persistence to last grade of primary 94.2% 2016 — 50th Private prepaid plans 10.3% 2011 down 42.2% 11th Health expenditure, private 44.9% 2011 down 3.3% 31st Health expenditure 2.86 billion current US$ 2011 up 144.9% 8th HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 0.0% 2014 down 100.0% 96th Social Security expenditure on health 47.7% 2011 up 71.9% 1st People living with HIV/AIDS, total 3,300 high estimate 2009 up 230.0% 47th People living with HIV/AIDS, total 1,800 low estimate 2009 up 1,700.0% 47th People living with HIV/AIDS, total 2,400 2009 up 140.0% 46th Proportion of bloodstream infection due to Escherichia coli resistant 26.1% 2023 up 2.5% 34th Proportion of bloodstream infection due to methicillin-resistant 14.8% 2023 down 39.6% 38th AIDS deaths in adults and children 200 high estimate 2009 up 100.0% 47th AIDS deaths in adults and children 100 low estimate 2009 unchanged 47th AIDS deaths in adults and children 100 2009 unchanged 46th Financial hardship in health and components (SDG 3.8.2, 2025) 31.1% 2021 up 32.2% 8th Total use of antibacterials expressed as DDD per 1000 inhabitants per 33.55 2023 up 7.6% 3rd Pattern of antibiotic consumption at national level 72.53 2023 down 5.0% 13th Government health expenditure per capita 130 current US$ 2009 up 97.0% 10th Commitments to recipient countries 12.61 2010 up 416.8% 96th Disbursements to recipient countries 10.21 2010 up 639.9% 101st Care-seeking for children with symptoms of acute respiratory infection 99.1% 2023 up 66.6% 1st Children aged <5 years wasted for age 2.8% 2012 down 3.4% 56th 4.1.1 Proportion of children and young people at the end of lower 25.19 2015 down 8.5% 53rd Deaths due to tuberculosis among HIV-negative people, high 5.6 per 100,000 population 2011 up 24.4% 50th Deaths due to tuberculosis among HIV-negative people, low uncertainty 1.3 per 100,000 population 2011 up 18.2% 49th 4.1.1 Proportion of children and young people at the end of lower 28.42 2015 down 30.7% 52nd Proportion of children at the end of lower secondary achieving at 25.2% 2015 down 8.5% 53rd New HIV infections, low estimate 500 2009 up 400.0% 47th New HIV infections, high estimate 1,000 2009 up 400.0% 47th HIV prevalence rate, adult 15-49 years 0.1% 2009 unchanged 45th HIV prevalence rate, adult 15-49 years 0.1% 2009 unchanged 44th Confirmed cases of MDR-TB started treatment for MDR-TB 100.0% 2012 — 3rd Sales of wine in 1000s hectolitres 210 2007 up 1.0% 16th Exports of spirits in 1000s hectolitres 19 2005 up 58.3% 52nd Exports of wine (grape) in 1000s hectolitres 90 2007 up 23.3% 22nd ← Previous Page 21 of 21